BiotechTube
Home/Pipeline/Minder iCEM

Minder iCEM

Drug‑resistant epilepsy

Phase 2Active

Key Facts

Indication
Drug‑resistant epilepsy
Phase
Phase 2
Status
Active
Company
Epiminder

About Epiminder

Epiminder delivers FDA‑authorised implantable continuous EEG monitoring to transform care for drug‑resistant epilepsy.

View full company profile

Therapeutic Areas

NeurologyEpilepsy

Other Drug‑resistant epilepsy Drugs

DrugCompanyPhase
eOPN3‑Drug‑Resistant EpilepsyModulight BioPreclinical